FERRETAB® COMP.
ABOUT BRAND
-
Brand name:
FERRETAB® COMP.
-
Dosage form:
Capsules
-
Composition:
1 capsule contains: 3 ferrous fumarate minipills and 1 folic acid minipill.
Active pharmaceutical substance: ferrous fumarate – 163,56 mg (solid equivalent to 152,1 mg, equivalent to 50 mg of ferrum); folic acid – 0,54 mg (solid equivalent to 0,5 mg).
Excipients: ferrous fumarate minipills: lactose monohydrate – 3,42 mg; colloidal silicon dioxide – 0,6 mg; magnesium – 0,6 mg; methyl methacrylate and ethyl acrylate copolymer [2 : 1] – 4,66 mg; folic acid minipill: lactose monohydrate – 24,21 mg; microcrystalline cellulose – 24,25 mg; colloidal silicon dioxide – 0,5 mg; magnesium – 0,5 mg.
Capsule body: gelatin – 36,4804 mg; azorubine dye – 0,0742 mg; quinoline yellow dye – 0,1484 mg; titanium dioxide – 0,4960 mg.
Capsule cap: gelatin – 24,3203 mg; azorubine dye – 0,0498 mg; quinoline yellow dye – 0,0996 mg; titanium dioxide – 0,3303 mg.
Combined medicines of iron organic salt and folic acid in capsules of prolonged action for the iron deficiency treatment and prevention, especially during pregnancy.
Description
Size 2 solid gelatin capsules, red body and cap. Capsule contains 3 reddish-brown round flat minipills (ferrous fumarate) and 1 yellow round flat minipill (folic acid). Inclusions are allowed on tablets.
Indications
Treatment and prevention of states caused by pregnancy, impaired iron absorption from the gastrointestinal tract, prolonged bleeding, unbalanced and deficient nutrition.
Counterindications
— Hypersensitivity to any of the drug components
— Diseases accompanied by accumulation of iron in the body (aplastic and hemolytic anemia, thalassemia, hemosiderosis, hemochromatosis)
— Iron absorption disorder (sideroachrestic anemia, lead anemia, pernicious anemia (vitamin B12 deficiency). Anemia that is not caused by iron or folic acid deficiency
English 
Русский